- Home
- AVIR vs EVBN Comparison
AVIR vs EVBN Comparison
Compare AVIR & EVBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- EVBN
- Stock Information
- Founded
- AVIR 2012
- EVBN 1920
- Country
- AVIR United States
- EVBN United States
- Employees
- AVIR N/A
- EVBN N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- EVBN Major Banks
- Sector
- AVIR Health Care
- EVBN Finance
- Exchange
- AVIR Nasdaq
- EVBN Nasdaq
- Market Cap
- AVIR 284.6M
- EVBN 231.8M
- IPO Year
- AVIR 2020
- EVBN N/A
- Fundamental
- Price
- AVIR $3.24
- EVBN $44.02
- Analyst Decision
- AVIR Hold
- EVBN Hold
- Analyst Count
- AVIR 1
- EVBN 2
- Target Price
- AVIR $6.88
- EVBN $36.25
- AVG Volume (30 Days)
- AVIR 505.9K
- EVBN 18.8K
- Earning Date
- AVIR 02-26-2025
- EVBN 01-30-2025
- Dividend Yield
- AVIR N/A
- EVBN 3.05%
- EPS Growth
- AVIR N/A
- EVBN N/A
- EPS
- AVIR N/A
- EVBN 3.34
- Revenue
- AVIR N/A
- EVBN $82,014,000.00
- Revenue This Year
- AVIR N/A
- EVBN N/A
- Revenue Next Year
- AVIR N/A
- EVBN $9.14
- P/E Ratio
- AVIR N/A
- EVBN $12.95
- Revenue Growth
- AVIR N/A
- EVBN N/A
- 52 Week Low
- AVIR $2.75
- EVBN $24.07
- 52 Week High
- AVIR $4.60
- EVBN $46.21
- Technical
- Relative Strength Index (RSI)
- AVIR 47.81
- EVBN 55.80
- Support Level
- AVIR $3.11
- EVBN $42.27
- Resistance Level
- AVIR $3.49
- EVBN $43.88
- Average True Range (ATR)
- AVIR 0.14
- EVBN 1.02
- MACD
- AVIR -0.00
- EVBN 0.10
- Stochastic Oscillator
- AVIR 26.58
- EVBN 90.73
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About EVBN Evans Bancorp Inc.
Evans Bancorp Inc is a financial holding company. Through its subsidiaries, it provides various banking services to consumers and commercial customers in the USA. The firm operates in two segments, Banking Activities and Insurance Agency Activities. The banking business segment includes both commercial and consumer banking services, including lending and depository services and offering non-deposit investment products, such as annuities and mutual funds. The insurance agency segment includes the activities of selling various premium-based insurance policies on a commission basis, including business and personal insurance, employee benefits, surety bonds, risk management, life, disability and long-term care coverage, and providing claims adjusting services to various insurance companies.